In contrast with classical MHC-I molecules (over 10,000 alleles), MR1 shows very little inter-individual variability (only 6 allele groups; [112]), which creates a huge opportunity for the application of MR1T cells in the therapy of bacterial infections and cancer. Here, MR1 is linked to cancer.